Natco Pharma posts Q4 net loss of Rs 61.30 cr
Follow us Now on Telegram ! Get daily 10 - 12 important updates on Business, Finance and Investment. Join our Telegram Channel
The company reported standalone net loss during the quarter stood at Rs 61.30 crore compared to net profit of Rs 57.20 crore in the previous year quarter. Net revenue of the company rose substantially by 65.04 per cent at Rs 514.10 crore in January-March quarter of this fiscal as against Rs 311.50 crore in the corresponding period last year. During January-March quarter, operating expenses increased by 134.71 per cent to Rs 551.80 crore from Rs 235.10 crore in year ago period. Other Income dipped by 64.26 per cent at Rs 10.40 crore versus (Mar'21 Rs 29.10 crore).
Operating Profit slipped by 149.35 per cent to Rs -37.70 crore as against Rs 76.40 crore in the year ago period, while Operating Profit Margin (OPM) contracted year-on-year to 129.88 per cent in March quarter. Interest grew by 82.61 per cent y-o-y to Rs 4.20 crore, while Taxation decreased by 135.80 per cent at Rs -5.80 crore (Mar'21 Rs 16.20 crore).
